GH is also implicated in tumor growth, altering regulation of the phosphoinositide-3-kinase–protein kinase B/Akt (PI3K/AKT) pathway, which leads to increased activation of mammalian target of rapamycin (mTOR) [1]. This evidence concerns the gene AKT1 and neoplasm.